Usp9x KD blocked the induction of SOX2 by vemurafenib or MEKi treatment in melanoma cell lines with mutant BRAF, A375 (Figure 3A), SK-Mel28 (Figure 3B) and wild type BRAF, SK-Mel147 (Figure 3C). Here, BRAF is linked to melanoma.